| 1 |
Lui GK, Saidi A, Bhatt AB, et al. Diagnosis and management of noncardiac complications in adults with congenital heart disease: a scientific statement from the American Heart Association. Circulation 2017;136:e348-92.
DOI
|
| 2 |
Dimopoulos K, Diller GP, Koltsida E, et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation 2008;117:2320-8.
DOI
|
| 3 |
Inatomi J, Matsuoka K, Fujimaru R, Nakagawa A, Iijima K. Mechanisms of development and progression of cyanotic nephropathy. Pediatr Nephrol 2006;21:1440-5.
DOI
|
| 4 |
Ronco C, McCullough P, Anker SD, et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J 2010;31:703-11.
DOI
|
| 5 |
Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 1999;341:577-85.
DOI
|
| 6 |
Magri P, Rao MA, Cangianiello S, et al. Early impairment of renal hemodynamic reserve in patients with asymptomatic heart failure is restored by angiotensin II antagonism. Circulation 1998;98:2849-54.
DOI
|
| 7 |
Taylor ML, Carmona F, Thiagarajan RR, et al. Mild postoperative acute kidney injury and outcomes after surgery for congenital heart disease. J Thorac Cardiovasc Surg 2013;146:146-52.
DOI
|
| 8 |
Collins RT 2nd. Cardiovascular disease in Williams syndrome. Circulation 2013;127:2125-34.
DOI
|
| 9 |
Oka H, Nakau K, Kajihama A, Azuma H. Assessment of potential renal dysfunction in patients with congenital heart disease after biventricular repair. Korean Circ J 2018;48:418-26.
DOI
|
| 10 |
Hongsawong N, Khamdee P, Silvilairat S, Chartapisak W. Prevalence and associated factors of renal dysfunction and proteinuria in cyanotic congenital heart disease. Pediatr Nephrol 2018;33:493-501.
DOI
|
webmaster
